ライフサイエンスコーパス: subdermal

1 erability, and pharmacokinetics of an annual subdermal 110 mg tenofovir alafenamide silicone reservoi

2 Hormone replacement with subdermal 17-beta-estradiol pellets releasing either 6,

3 d during the course of infection in a rabbit subdermal abscess model.

4 ncluding a reduction in body mass, a loss of subdermal adipose tissue, severe lordokyphosis, muscle a

5 Our findings suggest that the subdermal administration of AgNPs induced oxidative stre

6 Our results revealed that the subdermal administration of AgNPs induced significant in

7 Whereas subdermal and intracranial growth of weakly immunogenic

8 and 6.5% (not significant) for peritumoral, subdermal, and dermal injection techniques, respectively

9 t time the entire course of AVM formation in subdermal blood vessels by using intravital bright-field

10 ion and osteogenesis was examined in the rat subdermal calcification model by quantitative real-time

11 ning reflex in the anesthetized rat; forepaw subdermal capsaicin also elevated the mechanical hindpaw

12 This circuit was activated by subdermal capsaicin injection at a site remote from the

13 barrier function, transit across and to the subdermal compartment can be challenging.

14 ion, with more limited changes in dermal and subdermal compartments.

15 ion on highly effective (ie, intrauterine or subdermal) contraceptives, the iPLEDGE program increases

16 cal foreign body response (FBR) to sustained subdermal delivery of three forms of TAF, namely TAF fre

17 %, and the number of leukocytes invading the subdermal ear tissue was reduced.

18 Each pig was implanted with subdermal electrodes to capture electroencephalographic

19 We used four subdermal electrodes to record horizontal (h) and vertic

20 sion pathways were broadly downregulated and subdermal fat showed pronounced inflammation.

21 The reduced subdermal features in dry coupling can be enhanced throu

22 this transplantation site should be located subdermal for easy surgical-access but this never result

23 combination of variation in the location of subdermal growth beneath primordia and the merging of pr

24 g mouse models of acquired intramuscular and subdermal HO, we found that blockage of endogenous activ

25 hich include intrauterine devices (IUDs) and subdermal hormonal implants, are used by only a small mi

26 Overall, we present the ISL subdermal implant as a promising approach for LA ARV tre

27 ective reversible contraceptives such as the subdermal implant or intrauterine contraception; most co

28 e exploring the development of complementary subdermal implant technologies delivering the potent pro

29 raceptives increased for almost all methods (subdermal implant, 45% to 78% [P < .001]; IUD, 61% to 83

30 daily oral doses and continuous exposure via subdermal implant.

31 Specifically, subdermal implantable microphone technology has been poi

32 tforms weighing 110 mg with capabilities for subdermal implantation and tolerance to over 200,000 mul

33 Subdermal implantation of AlCl(3)-pretreated elastin sho

34 -2 was also examined in experimental mice by subdermal implantation of Matrigel plugs containing SMOC

35 small footprint of such devices enables full subdermal implantation that results in the capability to

36 are sufficiently small, thin, and light for subdermal implantation, offering some advantages over te

37 c aortic valve cusps by 80.0% ethanol in rat subdermal implants (60-day ethanol-pretreated calcium le

38 ted calcification of purified elastin in rat subdermal implants (Ca(2+) = 89.73 +/- 9.84 microgram/mg

39 Rat subdermal implants (porcine aortic cusps/bovine pericard

40 polycaprolactone have been used to formulate subdermal implants and injectable microspheres to elimin

41 LARC, high satisfaction rates among users of subdermal implants and IUDs, as well as varying pregnanc

42 hods include intrauterine devices (IUDs) and subdermal implants and show great promise for women with

43 Levonorgestrel subdermal implants are preferred contraceptives with an

44 Participants received islatravir or placebo subdermal implants for 12 weeks and were monitored throu

45 ble contraceptives, intrauterine devices and subdermal implants have the highest effectiveness, and p

46 -acting, controlled drug administration from subdermal implants holds significant potential by reduci

47 However, BP-POZ rat subdermal implants with ethanol pretreatment demonstrate

48 luded that purified elastin calcifies in rat subdermal implants, and that the AlCl(3)-pretreated elas

49 In juvenile rat subdermal implants, BP-POZ demonstrated reduced AGE form

50 ng methods, such as intrauterine devices and subdermal implants, has increased substantially, from 6%

51 on of elastin calcification using 21-day rat subdermal implants, irrespective of glutaraldehyde cross

52 intrauterine devices (IUDs), injectables and subdermal implants.

53 edient (API) suspensions, ionic liquids, and subdermal implants.

54 ve power storage on the platform of wireless subdermal implants.

55 We found that intense noxious stimuli (i.e., subdermal injection of capsaicin or paw immersion in hot

56 tification rate compared with peritumoral or subdermal injection.

57 Here we show constant ISL release from a subdermal LA nanofluidic implant achieves viral load red

58 CR10 levels in dorsal skin of db/db mice and subdermal leg biopsy specimens from human subjects with

59 The devices combine subdermal magnetic coil antennas connected to microscale

60 tome and limb bud mesenchyme and, later, the subdermal mesenchyme and the chondrocytes of the develop

61 e invasive disease (eg, spinal, orbital, and subdermal nodules).

62 by the use of dermal injection compared with subdermal or peritumoral injection of radioactive colloi

63 Peritumoral, subdermal, or dermal injection of radioactive colloid wa

64 Peritumoral, subdermal, or dermal injection of radioactive colloid wa

65 Dermal, subdermal, peritumoral, or subareolar radioactive colloi

66 light historically limits implementation to subdermal regions, necessitating alternative methods of

67 0.007), concentrations of gametocytes in the subdermal skin vasculature were not higher compared to o

68 uction to imaging, enabling visualization of subdermal structures and fluorophores in situ.

69 the preclinical pharmacology of long-acting, subdermal TAF delivery using several mouse models.

70 plantation studies for glucose monitoring in subdermal tissue.

71 sease, a fibrotic disorder of the dermis and subdermal tissues of the palm.

72 s commonly used for treating superficial and subdermal tumors.

73 image of the fingerprint, as well as unique subdermal vasculature structures, making the system almo

74 Reticular veins are subdermal veins located in the lower limbs and are mainl